Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Towards diagnostic criteria for malignant deep penetrating melanocytic tumors using single nucleotide polymorphism array and next-generation sequencing.
Ebbelaar CF, Schrader AMR, van Dijk M, Meijers RWJ, de Leng WWJ, Bloem LT, Jansen AML, Blokx WAM; MOLecular Evaluation of Melanocytic Ambiguous Tumors (MOLEMAT) investigators. Ebbelaar CF, et al. Among authors: schrader amr. Mod Pathol. 2022 Aug;35(8):1110-1120. doi: 10.1038/s41379-022-01026-6. Epub 2022 Feb 19. Mod Pathol. 2022. PMID: 35184152 Free article.
Ambiguous melanocytic lesions: A retrospective cohort study of incidence and outcome of melanocytic tumor of uncertain malignant potential (MELTUMP) and superficial atypical melanocytic proliferation of uncertain significance (SAMPUS) in the Netherlands.
Vermariën-Wang J, Doeleman T, van Doorn R, Mooyaart AL, Blokx WAM, Schrader AMR. Vermariën-Wang J, et al. Among authors: schrader amr. J Am Acad Dermatol. 2023 Mar;88(3):602-608. doi: 10.1016/j.jaad.2022.11.019. Epub 2022 Nov 18. J Am Acad Dermatol. 2023. PMID: 36403750 Free article. Review.
Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma.
van Duin IAJ, Schuiveling M, Ter Maat LS, van Amsterdam WAC, van den Berkmortel F, Boers-Sonderen M, de Groot JWB, Hospers GAP, Kapiteijn E, Labots M, Piersma D, Schrader AMR, Vreugdenhil G, Westgeest H, Veta M, Blokx WAM, van Diest PJ, Suijkerbuijk KPM. van Duin IAJ, et al. Among authors: schrader amr. Eur J Cancer. 2024 Sep;208:114190. doi: 10.1016/j.ejca.2024.114190. Epub 2024 Jun 30. Eur J Cancer. 2024. PMID: 38991284 Free article.
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma.
van Duin IAJ, Schuiveling M, Ter Maat LS, Veta M, van Eijs MJM, Verheijden RJ, van den Berkmortel FWPJ, Boers-Sonderen MJ, Hospers GAP, Labots M, de Groot JWB, Kapiteijn E, Piersma D, Vreugdenhil G, Westgeest H, Schrader AMR, van Diest PJ, Blokx WAM, Suijkerbuijk KPM. van Duin IAJ, et al. Among authors: schrader amr. Immunooncol Technol. 2024 Jun 12;24:100714. doi: 10.1016/j.iotech.2024.100714. eCollection 2024 Dec. Immunooncol Technol. 2024. PMID: 39045171 Free PMC article.
Deep Learning-Based Classification of Early-Stage Mycosis Fungoides and Benign Inflammatory Dermatoses on H&E-Stained Whole-Slide Images: A Retrospective, Proof-of-Concept Study.
Doeleman T, Brussee S, Hondelink LM, Westerbeek DWF, Sequeira AM, Valkema PA, Jansen PM, He J, Vermeer MH, Quint KD, van Dijk MR, Verbeek FJ, Kers J, Schrader AMR. Doeleman T, et al. Among authors: schrader amr. J Invest Dermatol. 2024 Sep 19:S0022-202X(24)02101-8. doi: 10.1016/j.jid.2024.07.036. Online ahead of print. J Invest Dermatol. 2024. PMID: 39306030 Free article.
The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis.
Hondelink LM, Schrader AMR, Asri Aghmuni G, Solleveld-Westerink N, Cleton-Jansen AM, van Egmond D, Boot A, Ouahoud S, Khalifa MN, Wai Lam S, Morreau H, Bovee JVMG, van Wezel T, Cohen D. Hondelink LM, et al. Among authors: schrader amr. Eur J Cancer. 2022 Sep;173:229-237. doi: 10.1016/j.ejca.2022.06.030. Epub 2022 Aug 4. Eur J Cancer. 2022. PMID: 35933886 Free article.
25 results